Skip to main content
. 2021 May 20;13(5):757. doi: 10.3390/pharmaceutics13050757

Figure 5.

Figure 5

Examples of nanodelivery systems for rtPA to extend the half-life of the therapeutic agent, to reduce secondary effects, improve the recanalization, target the therapy, and improve the efficacy. Figure created with BioRender.com.